Most Recent
Maker of ‘Rebel Whopper’ takes patent beef to court
The start-up behind Hungry Jack's plant-based 'Rebel Whopper' wants a court to review IP Australia's decision that a proposed patent covering its fake meat product didn't pass muster.
Zenith Energy accused of infringing patents for renewable grid system
Danish company Vestesen Hybrid Energy has taken Zenith Energy to court for allegedly infringing its patented system for operating an electrical grid where energy is generated by a fluctuating renewable energy source. 
‘Rebel Whopper’ maker can’t patent product to mimic ‘meat experience’
V2food, the CSIRO-backed start-up behind Hungry Jack's plant-based 'Rebel Whopper', has lost its bid to patent a product that changes colour when cooked in order to imitate the “meat experience”.
Zoetis hit with costs in bovine gene patent spat
Zoetis has been ordered to pay Scidera’s costs of defending an unsuccessful summary dismissal application on a lump sum basis in a dispute over a bovine gene patent, with a judge rejecting its “premature” bid for a set-off. 
Regeneron, Bayer settle appeal over launch of Sandoz’s Eylea biosimilar
Biotech Regeneron and drug company Bayer have resolved their appeal of a ruling that allowed generic pharmaceutical manufacturer Sandoz to launch a version of top selling macular degeneration drug Eylea. 
Judge ‘running out of patience’ in Scidera’s bovine gene patent suit
A judge has declined to order US-based animal genomics company Scidera to file a position statement in its bovine gene patent infringement suit and said she was “running out of patience” after unsuccessful strike-out and summary dismissal applications by the defendants.
Scidera’s bovine gene patent suit survives summary dismissal bid
Animal drug company Zoetis has lost its bid for summary dismissal of claims that it infringed US-based animal genomics company Scidera's bovine gene patent, with a judge saying its novel arguments were not so clear-cut and needed to be worked out at trial.
Samsung Bioepis shoots down Janssen patent for ulcerative colitis biologic
Samsung Bioepis has successfully opposed Janssen's bid to patent a monoclonal antibody to treat ulcerative colitis, but an IP Australia delegate has given the J&J-owned company a chance to fix its application.
Regeneron, Bayer take fight over Eylea biosimilar to appeals court
Biotech Regeneron and drug company Bayer have wasted no time in challenging a decision that cleared the way for generic pharmaceutical manufacturer Sandoz to launch a version of top selling Eylea.
Vehicle Monitoring must choose now between damages, account of profits in IP spat
A judge has ordered tech company Vehicle Management Systems to hurry up and choose between damages or an account of profits in its IP dispute with the city of Melbourne over a sensor-based system for timing parked vehicles.